Aya Alame
University of Texas Southwestern Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Aya Alame.
International Journal of Cardiology | 2016
Aris Karatasakis; Barbara Anna Danek; Dimitri Karmpaliotis; Khaldoon Alaswad; Farouc A. Jaffer; Robert W. Yeh; Mitul Patel; John Bahadorani; William Lombardi; R. Michael Wyman; J. Aaron Grantham; David E. Kandzari; Nicholas Lembo; Anthony Doing; Catalin Toma; Jeffrey W. Moses; Ajay J. Kirtane; Manish Parikh; Ziad Ali; Santiago Garcia; Pratik Kalsaria; Judit Karacsonyi; Aya Alame; Craig A. Thompson; Subhash Banerjee; Emmanouil S. Brilakis
BACKGROUND Various scoring systems have been developed to predict the technical outcome and procedural efficiency of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). METHODS We examined the predictive capacity of 3 CTO PCI scores (Clinical and Lesion-related [CL], Multicenter CTO registry in Japan [J-CTO] and Prospective Global Registry for the Study of Chronic Total Occlusion Intervention [PROGRESS CTO] scores) in 664 CTO PCIs performed between 2012 and 2016 at 13 US centers. RESULTS Technical success was 88% and the retrograde approach was utilized in 41%. Mean CL, J-CTO and PROGRESS CTO scores were 3.9±1.9, 2.6±1.2 and 1.4±1.0, respectively. All scores were inversely associated with technical success (p<0.001 for all) and had moderate discriminatory capacity (area under the curve 0.691 for the CL score, 0.682 for the J-CTO score and 0.647 for the PROGRESS CTO score [p=non-significant for pairwise comparisons]). The difference in technical success between the minimum and maximum CL score strata was the highest (32%, vs. 15% for J-CTO and 18% for PROGRESS CTO scores). All scores tended to perform better in antegrade-only procedures and correlated significantly with procedure time and fluoroscopy dose; the CL score also correlated significantly with contrast utilization. CONCLUSIONS CL, J-CTO and PROGRESS CTO scores perform moderately in predicting technical outcome of CTO PCI, with better performance for antegrade-only procedures. All scores correlate with procedure time and fluoroscopy dose, and the CL score also correlates with contrast utilization.
Catheterization and Cardiovascular Interventions | 2017
Judit Karacsonyi; Dimitri Karmpaliotis; Khaldoon Alaswad; Farouc A. Jaffer; Robert W. Yeh; Mitul Patel; John Bahadorani; Anthony Doing; Ziad Ali; Aris Karatasakis; Barbara Anna Danek; Bavana V. Rangan; Aya Alame; Subhash Banerjee; Emmanouil S. Brilakis
Balloon uncrossable lesions can be challenging to treat, requiring specialized techniques and equipment.
Journal of the American Heart Association | 2016
Judit Karacsonyi; Khaldoon Alaswad; Farouc A. Jaffer; Robert W. Yeh; Mitul Patel; John Bahadorani; Aris Karatasakis; Barbara Anna Danek; Anthony Doing; J. Aaron Grantham; Dimitri Karmpaliotis; Jeffrey W. Moses; Ajay J. Kirtane; Manish Parikh; Ziad Ali; William Lombardi; David E. Kandzari; Nicholas Lembo; Santiago Garcia; Michael R. Wyman; Aya Alame; Phuong Khanh J Nguyen-Trong; Erica Resendes; Pratik Kalsaria; Bavana V. Rangan; Imre Ungi; Craig A. Thompson; Subhash Banerjee; Emmanouil S. Brilakis
Background Intravascular imaging can facilitate chronic total occlusion (CTO) percutaneous coronary intervention. Methods and Results We examined the frequency of use and outcomes of intravascular imaging among 619 CTO percutaneous coronary interventions performed between 2012 and 2015 at 7 US centers. Mean age was 65.4±10 years and 85% of the patients were men. Intravascular imaging was used in 38%: intravascular ultrasound in 36%, optical coherence tomography in 3%, and both in 1.45%. Intravascular imaging was used for stent sizing (26.3%), stent optimization (38.0%), and CTO crossing (35.7%, antegrade in 27.9%, and retrograde in 7.8%). Intravascular imaging to facilitate crossing was used more frequently in lesions with proximal cap ambiguity (49% versus 26%, P<0.0001) and with retrograde as compared with antegrade‐only cases (67% versus 31%, P<0.0001). Despite higher complexity (Japanese CTO score: 2.86±1.19 versus 2.43±1.19, P=0.001), cases in which imaging was used for crossing had similar technical and procedural success (92.8% versus 89.6%, P=0.302 and 90.1% versus 88.3%, P=0.588, respectively) and similar incidence of major cardiac adverse events (2.7% versus 3.2%, P=0.772). Use of intravascular imaging was associated with longer procedure (192 minutes [interquartile range 130, 255] versus 131 minutes [90, 192], P<0.0001) and fluoroscopy (71 minutes [44, 93] versus 39 minutes [25, 69], P<0.0001) time. Conclusions Intravascular imaging is frequently performed during CTO percutaneous coronary intervention both for crossing and for stent selection/optimization. Despite its use in more complex lesion subsets, intravascular imaging was associated with similar rates of technical and procedural success for CTO percutaneous coronary intervention. Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT02061436.
Eurointervention | 2016
Aris Karatasakis; Dimitri Karmpaliotis; Khaldoon Alaswad; Farouc A. Jaffer; Robert W. Yeh; Mitul Patel; John Bahadorani; William Lombardi; R. Michael Wyman; J. Aaron Grantham; David E. Kandzari; Nicholas Lembo; Anthony Doing; Catalin Toma; Jeffrey W. Moses; Ajay J. Kirtane; Ziad Ali; Manish Parikh; Santiago Garcia; Barbara Anna Danek; Judit Karacsonyi; Aya Alame; Pratik Kalsaria; Craig A. Thompson; Subhash Banerjee; Emmanouil S. Brilakis
AIMS The goal of this study was to describe the procedural characteristics, strategy selection and associated technical and efficiency outcomes for chronic total occlusion (CTO) percutaneous coronary intervention (PCI) of the right coronary artery (RCA). METHODS AND RESULTS We examined the clinical and angiographic characteristics of patients who underwent RCA CTO PCI between 2012 and 2015 at 11 centres in the USA. The RCA was the CTO target vessel in 739 of 1,308 CTO PCIs (56%). Overall technical and procedural success rates were 90% and 88%, respectively. A major adverse cardiovascular event (MACE) occurred in 19 patients (2.6%). Technical success was most frequently achieved using antegrade wire escalation (38% of successful procedures) followed by retrograde (36%) and antegrade dissection/re-entry (26%). Technical success was similar between various locations of RCA CTOs (p=0.11). Compared with antegrade-only procedures, utilisation of any retrograde approach was associated with lower technical (85% vs. 95%, p<0.001) and procedural (82% vs. 94%, p<0.001) success and a higher MACE rate (3.8% vs. 1.4%, p=0.037). CONCLUSIONS RCA CTOs represent the majority of CTO target lesions, can be treated with high success and acceptable complication rates, and require frequent use of the retrograde approach and antegrade dissection/re-entry.
Catheterization and Cardiovascular Interventions | 2018
Aris Karatasakis; Harilaos S. Brilakis; Barbara Anna Danek; Judit Karacsonyi; Jose Roberto Martinez-Parachini; Phuong Khanh J Nguyen-Trong; Aya Alame; Michele Roesle; Bavana V. Rangan; Kenneth Rosenfield; Roxana Mehran; Ehtisham Mahmud; Charles E. Chambers; Subhash Banerjee; Emmanouil S. Brilakis
To examine the relationship between occupational exposure to ionizing radiation and the prevalence of lens changes in interventional cardiologists (ICs) and catheterization laboratory (“cath‐lab”) staff.
Diabetic Medicine | 2017
Jose Roberto Martinez-Parachini; Aris Karatasakis; Dimitri Karmpaliotis; Khaldoon Alaswad; Farouc A. Jaffer; Robert W. Yeh; Mitul Patel; John Bahadorani; Anthony Doing; Phuong Khanh J Nguyen-Trong; Barbara Anna Danek; Judit Karacsonyi; Aya Alame; Bavana V. Rangan; Craig A. Thompson; Subhash Banerjee; Emmanouil S. Brilakis
To examine the impact of diabetes mellitus on procedural outcomes of patients who underwent percutaneous coronary intervention for chronic total occlusion.
Catheterization and Cardiovascular Interventions | 2016
Aya Alame; Emmanouil S. Brilakis
Percutaneous coronary intervention of ostial lesions can be fraught with multiple challenges. Intravascular ultrasound detects imperfect stenting results (stent underexpansion and incomplete ostial coverage) in approximately half of imaged ostial lesions. Corrective actions based on intravascular ultrasound imaging can improve the long‐term outcomes of patients undergoing ostial lesion stenting.
Catheterization and Cardiovascular Interventions | 2017
Barbara Anna Danek; Aris Karatasakis; Aya Alame; Phuong Khanh J Nguyen-Trong; Judit Karacsonyi; Bavana V. Rangan; Michele Roesle; Amy Atwell; Erica Resendes; Jose Roberto Martinez-Parachini; Rahel Iwnetu; Pratik Kalsaria; Furqan Siddiqui; James E. Muller; Subhash Banerjee; Emmanouil S. Brilakis
We sought to examine near‐infrared spectroscopy (NIRS) imaging findings of aortocoronary saphenous vein grafts (SVGs).
Continuing Cardiology Education | 2016
Barbara Anna Danek; Aris Karatasakis; Judit Karacsonyi; Aya Alame; Pratik Kalsaria; Erica Resendes; Bavana V. Rangan; Subhash Banerjee; Emmanouil S. Brilakis
Coronary near‐infrared spectroscopy (NIRS) is an intravascular imaging modality with high sensitivity and specificity for lipid core plaque detection. A combined modality catheter that coregisters NIRS measurements with intravascular ultrasound (IVUS) is available, providing the operator with both structural and compositional data. NIRS/IVUS can identify plaques at risk for periprocedural myocardial infarction during stenting, allowing implementation of preventive strategies. NIRS/IVUS is currently being studied for identification of vulnerable plaques and vulnerable patients at risk of future cardiovascular events.
Catheterization and Cardiovascular Interventions | 2016
Phuong Khanh J Nguyen-Trong; Jose Roberto Martinez Parachini; Erica Resendes; Aris Karatasakis; Barbara Anna Danek; Aya Alame; Lorenza Makke; Colby R. Ayers; Michele Roesle; Bavana V. Rangan; Subhash Banerjee; Emmanouil S. Brilakis
The Flash Ostial system (Ostial Corporation, Sunnyvale, CA) was designed to optimize implantation of aorto‐ostial coronary stents by flaring the proximal stent struts against the aortic wall.